Meloxicam Bluefish (Meloxicam)

Meloxicam selectively blocks the cyclooxygenase‑2 (COX‑2) enzyme, which reduces the production of prostaglandins—chemical mediators that cause inflammation, pain, and fever. By lowering prostaglandin levels, meloxicam diminishes the inflammatory response and provides analgesic effects.

The appropriate dose of meloxicam is determined by the prescribing healthcare professional based on the patient’s condition, severity, and individual response. Dosage may vary, and patients should follow the prescriber’s instructions without self‑adjusting the amount.

Safety of meloxicam in pregnancy and lactation has not been fully established. It should be avoided unless the potential benefit justifies the potential risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives with their healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request trade or institutional credentials. The team then replies with pricing, availability, shipping details and any necessary import documentation.

Meloxicam offers a once‑daily dosing schedule due to its longer half‑life, which can improve adherence compared with shorter‑acting NSAIDs like ibuprofen. It is more COX‑2 selective, potentially providing a lower risk of gastrointestinal irritation, but it still carries cardiovascular and renal warnings similar to other NSAIDs.

Meloxicam Bluefish should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

The medication is taken orally, usually with a full glass of water. It can be taken with or without food, although taking it with food may reduce stomach upset. Patients should swallow tablets whole and not split, crush, or chew them unless instructed otherwise.

Serious risks include gastrointestinal ulceration or bleeding, cardiovascular events such as heart attack or stroke, severe liver injury, acute kidney failure, and rare but life‑threatening skin reactions like Stevens‑Johnson syndrome. Patients should seek immediate medical attention if they notice signs of these conditions.

Meloxicam is contraindicated in individuals with known hypersensitivity to meloxicam or other NSAIDs, active gastrointestinal ulceration or bleeding, severe heart failure, and those who have had a recent coronary artery bypass graft. Caution is also advised for patients with impaired renal or hepatic function.